Menu
GeneBe

DSG2

desmoglein 2, the group of Desmosomal cadherins

Basic information

Region (hg38): 18:31498176-31549008

Links

ENSG00000046604NCBI:1829OMIM:125671HGNC:3049Uniprot:Q14126AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • arrhythmogenic right ventricular dysplasia 10 (Definitive), mode of inheritance: AD
  • familial isolated dilated cardiomyopathy (Supportive), mode of inheritance: AD
  • arrhythmogenic right ventricular dysplasia 10 (Strong), mode of inheritance: AD
  • dilated cardiomyopathy 1BB (Limited), mode of inheritance: AR
  • dilated cardiomyopathy 1BB (Limited), mode of inheritance: AR
  • arrhythmogenic right ventricular dysplasia 10 (Definitive), mode of inheritance: AD
  • arrhythmogenic right ventricular dysplasia 10 (Definitive), mode of inheritance: AR
  • arrhythmogenic right ventricular dysplasia 10 (Moderate), mode of inheritance: AR
  • dilated cardiomyopathy (Limited), mode of inheritance: AD
  • arrhythmogenic right ventricular cardiomyopathy (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cardiomyopathy, dilated, 1BB; Arrhythmogenic right ventricular dysplasia, familial, 10ADCardiovascularIn Arrhythmogenic right ventricular dysplasia, familial, 10, individuals may manifest with syncope, cardiac arrest, and sudden death, and surveillance may allow early diagnosis of sequelae; Preventive measures (eg, with antiarrhythmic pharmacologic agents and/or ICD placement) may be beneficial, though some individuals may require heart transplantation; In Dilated cardiomyopathy; surveillance (eg, with echocardiography) may allow early detection of sequelae and medical management, which may decreased morbidity and mortality; Cardiac transplantation has been describedCardiovascular16773573; 16505173; 17105751; 18678517; 20301310

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DSG2 gene.

  • Arrhythmogenic right ventricular dysplasia 10 (1063 variants)
  • Cardiomyopathy (714 variants)
  • Cardiovascular phenotype (420 variants)
  • not provided (349 variants)
  • not specified (204 variants)
  • Arrhythmogenic right ventricular dysplasia 10;Dilated cardiomyopathy 1BB (75 variants)
  • Arrhythmogenic right ventricular cardiomyopathy (72 variants)
  • Dilated cardiomyopathy 1BB;Arrhythmogenic right ventricular dysplasia 10 (30 variants)
  • Dilated Cardiomyopathy, Dominant (25 variants)
  • Inborn genetic diseases (16 variants)
  • Primary dilated cardiomyopathy (7 variants)
  • Dilated cardiomyopathy 1BB (6 variants)
  • DSG2-related condition (6 variants)
  • Primary familial hypertrophic cardiomyopathy (5 variants)
  • Long QT syndrome (4 variants)
  • Hypertrophic cardiomyopathy (4 variants)
  • Arrhythmogenic right ventricular dysplasia 1 (3 variants)
  • Cardiac arrest (3 variants)
  • Primary familial dilated cardiomyopathy (2 variants)
  • Arrhythmogenic right ventricular dysplasia 9 (2 variants)
  • Cardiomyopathy;Restrictive cardiomyopathy (2 variants)
  • Cardiac arrhythmia (1 variants)
  • Familial isolated dilated cardiomyopathy (1 variants)
  • Ventricular fibrillation (1 variants)
  • Intellectual disability (1 variants)
  • Cardiomyopathy;Systolic heart failure (1 variants)
  • Arrhythmogenic right ventricular cardiomyopathy;Cardiomyopathy (1 variants)
  • Primary dilated cardiomyopathy;Cardiomyopathy (1 variants)
  • Sudden cardiac death (1 variants)
  • Conduction disorder of the heart (1 variants)
  • Catecholaminergic polymorphic ventricular tachycardia 1 (1 variants)
  • Left ventricular noncompaction cardiomyopathy (1 variants)
  • Dilated cardiomyopathy 1A (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DSG2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
280
clinvar
6
clinvar
289
missense
1
clinvar
4
clinvar
716
clinvar
26
clinvar
5
clinvar
752
nonsense
11
clinvar
12
clinvar
4
clinvar
27
start loss
1
clinvar
3
clinvar
4
frameshift
23
clinvar
27
clinvar
21
clinvar
71
inframe indel
19
clinvar
19
splice donor/acceptor (+/-2bp)
1
clinvar
22
clinvar
3
clinvar
26
splice region
24
33
57
non coding
59
clinvar
98
clinvar
41
clinvar
198
Total 36 66 828 404 52

Highest pathogenic variant AF is 0.0000200

Variants in DSG2

This is a list of pathogenic ClinVar variants found in the DSG2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
18-31498197-G-C Arrhythmogenic right ventricular dysplasia 10 Conflicting classifications of pathogenicity (Jan 13, 2018)326467
18-31498202-AGGCGGCGGCGCGGAGCGGTGC-A Cardiomyopathy Uncertain significance (Oct 14, 2016)188443
18-31498208-C-A Arrhythmogenic right ventricular cardiomyopathy • Dilated Cardiomyopathy, Dominant Uncertain significance (Jun 14, 2016)326468
18-31498215-G-C Benign (Mar 03, 2015)1269521
18-31498219-G-A Arrhythmogenic right ventricular dysplasia 10 • Arrhythmogenic right ventricular dysplasia 10;Dilated cardiomyopathy 1BB Uncertain significance (Jul 14, 2021)890672
18-31498226-CGGCGGGAGGCGGAGGCGAGGGTGCGAT-C Uncertain significance (Dec 01, 2020)1012911
18-31498230-G-A not specified Likely benign (Oct 26, 2015)380755
18-31498234-G-GGCGGAGGCGAGGGTGCGATGGC Cardiovascular phenotype Uncertain significance (May 01, 2023)2563307
18-31498236-C-G not specified Likely benign (Aug 17, 2016)388620
18-31498237-G-A not specified • Cardiomyopathy Uncertain significance (Dec 23, 2019)163198
18-31498240-G-A Cardiomyopathy Uncertain significance (Dec 18, 2019)922399
18-31498241-G-A not specified • Cardiomyopathy Uncertain significance (Mar 16, 2023)178664
18-31498244-AG-A Arrhythmogenic right ventricular cardiomyopathy Uncertain significance (Feb 05, 2024)3075425
18-31498248-T-G Dilated Cardiomyopathy, Dominant • Arrhythmogenic right ventricular cardiomyopathy Uncertain significance (Jun 14, 2016)326469
18-31498249-G-A Cardiomyopathy Uncertain significance (Feb 23, 2022)926635
18-31498250-C-T Cardiomyopathy Uncertain significance (Dec 21, 2020)1171237
18-31498251-G-A Arrhythmogenic right ventricular cardiomyopathy Uncertain significance (May 16, 2023)3071043
18-31498251-G-C Cardiomyopathy • Cardiovascular phenotype Conflicting classifications of pathogenicity (Jul 26, 2023)510690
18-31498252-A-C Cardiomyopathy Uncertain significance (May 03, 2021)924921
18-31498252-A-T Cardiomyopathy Uncertain significance (Oct 07, 2020)1172391
18-31498254-G-A Arrhythmogenic right ventricular dysplasia 10 • Arrhythmogenic right ventricular cardiomyopathy Conflicting classifications of pathogenicity (Jan 17, 2024)657863
18-31498257-G-A not specified • Cardiovascular phenotype • Arrhythmogenic right ventricular dysplasia 10 • Cardiomyopathy • DSG2-related disorder • Arrhythmogenic right ventricular cardiomyopathy Benign/Likely benign (Feb 05, 2024)137166
18-31498257-G-T Cardiomyopathy Likely benign (Jul 13, 2020)1171456
18-31498258-C-G Arrhythmogenic right ventricular dysplasia 10 Uncertain significance (Nov 14, 2023)2695863
18-31498257-G-GCGGAGGCGAGGGTGCGATGGCA Arrhythmogenic right ventricular dysplasia 10 Pathogenic (Jan 14, 2023)2828585

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DSG2protein_codingprotein_codingENST00000261590 1550966
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.79e-100.9951246990991247980.000397
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2965675870.9660.00002997316
Missense in Polyphen188201.620.932442621
Synonymous0.6732072200.9420.00001282243
Loss of Function2.612239.70.5530.00000186532

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006150.000615
Ashkenazi Jewish0.000.00
East Asian0.001280.00128
Finnish0.0001860.000186
European (Non-Finnish)0.0003650.000353
Middle Eastern0.001280.00128
South Asian0.0004360.000425
Other0.0006640.000660

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of intercellular desmosome junctions. Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion.;
Disease
DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 10 (ARVD10) [MIM:610193]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:16773573, ECO:0000269|PubMed:19863551, ECO:0000269|PubMed:20031617, ECO:0000269|PubMed:21062920}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1BB (CMD1BB) [MIM:612877]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:18678517}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);miR-targeted genes in muscle cell - TarBase;Arrhythmogenic Right Ventricular Cardiomyopathy;Keratinization;Developmental Biology;Apoptotic cleavage of cell adhesion proteins;Apoptotic cleavage of cellular proteins;Apoptotic execution phase;Apoptosis;Programmed Cell Death;EGFR1;Formation of the cornified envelope (Consensus)

Recessive Scores

pRec
0.147

Intolerance Scores

loftool
0.783
rvis_EVS
2.3
rvis_percentile_EVS
98.32

Haploinsufficiency Scores

pHI
0.435
hipred
Y
hipred_score
0.687
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.507

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Dsg2
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype;

Zebrafish Information Network

Gene name
dsg2.1
Affected structure
post-vent region
Phenotype tag
abnormal
Phenotype quality
curved

Gene ontology

Biological process
desmosome organization;Purkinje myocyte development;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;keratinization;response to progesterone;maternal process involved in female pregnancy;cornification;bundle of His cell-Purkinje myocyte adhesion involved in cell communication;regulation of heart rate by cardiac conduction;regulation of ventricular cardiac muscle cell action potential
Cellular component
cornified envelope;plasma membrane;cell-cell junction;cell surface;intercalated disc;integral component of membrane;apical plasma membrane;lateral plasma membrane;cell junction;desmosome;intracellular membrane-bounded organelle;extracellular exosome
Molecular function
calcium ion binding;cell adhesion molecule binding;cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication